Similar articles for PMID: 10871019

Year	Number of Results
1990	1
1991	1
1992	1
1994	2
1995	5
1996	2
1997	2
1998	6
1999	1
2000	6
2001	5
2002	7
2003	4
2004	8
2005	7
2006	7
2007	9
2008	4
2009	4
2010	3
2011	2
2012	4
2013	5
2014	4
2015	1
2018	1
2019	2
2020	1
2022	1

1

Effects of contrast material on single-volume proton MR spectroscopy.

Smith JK, Kwock L, Castillo M. Smith JK, et al. AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1084-9. AJNR Am J Neuroradiol. 2000. PMID: 10871019 Free PMC article.

2

Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T. Bulakbasi N, et al. AJNR Am J Neuroradiol. 2003 Feb;24(2):225-33. AJNR Am J Neuroradiol. 2003. PMID: 12591638 Free PMC article.

3

Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.

Ishimaru H, Morikawa M, Iwanaga S, Kaminogo M, Ochi M, Hayashi K. Ishimaru H, et al. Eur Radiol. 2001;11(9):1784-91. doi: 10.1007/s003300000814. Eur Radiol. 2001. PMID: 11511902

4

Proton MR spectroscopy of pediatric cerebellar tumors.

Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA. Wang Z, et al. AJNR Am J Neuroradiol. 1995 Oct;16(9):1821-33. AJNR Am J Neuroradiol. 1995. PMID: 8693982 Free PMC article.

5

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Law M, et al. AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98. AJNR Am J Neuroradiol. 2003. PMID: 14625221 Free PMC article.

6

Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.

Cirak B, Horská A, Barker PB, Burger PC, Carson BS, Avellino AM. Cirak B, et al. Childs Nerv Syst. 2005 May;21(5):404-9. doi: 10.1007/s00381-004-1023-2. Epub 2004 Sep 11. Childs Nerv Syst. 2005. PMID: 15372294

7

[Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].

Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU. Lichy MP, et al. Rofo. 2006 Jun;178(6):627-33. doi: 10.1055/s-2006-926744. Epub 2006 May 15. Rofo. 2006. PMID: 16703499 German.

8

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH. Server A, et al. Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901. Acta Radiol. 2010. PMID: 20092374

9

Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.

Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R. Castillo M, et al. AJNR Am J Neuroradiol. 1995 Jan;16(1):141-7. AJNR Am J Neuroradiol. 1995. PMID: 7900583 Free PMC article.

10

In vivo proton magnetic resonance spectroscopy of brain tumors.

Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF 3rd, Johnston KW, Robinson JS Jr, Papadakis N. Fountas KN, et al. Stereotact Funct Neurosurg. 2000;74(2):83-94. doi: 10.1159/000056467. Stereotact Funct Neurosurg. 2000. PMID: 11251398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed